Home › Funds › Two Sigma Investments › FDMT
Two Sigma Investments position in FDMT
4D MOLECULAR THERAPEUTICS IN · Health Care
Latest position (Q2 2026)69.48K sh
Reported value held$924.10K
Portfolio Weight0.00%
First reportedQ4 2021
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2021 | 70.85K | $1.55M | New |
| Q1 2022 | 15.70K | $237.00K | Reduce |
| Q2 2022 | 45.99K | $321.00K | Add |
| Q3 2022 | 16.45K | $132.00K | Reduce |
| Q4 2022 | 153.97K | $3.42M | Add |
| Q1 2023 | 200.88K | $3.45M | Add |
| Q2 2023 | 185.14K | $3.35M | Reduce |
| Q3 2023 | 101.86K | $1.30M | Reduce |
| Q1 2024 | 31.40K | $1.00M | New |
| Q2 2024 | 27.52K | $577.71K | Reduce |
| Q3 2024 | 105.97K | $1.15M | Add |
| Q4 2024 | 313.99K | $1.75M | Add |
| Q1 2025 | 461.46K | $1.49M | Add |
| Q1 2025 | 461.46K | $1.49M | Add |
| Q2 2025 | 531.16K | $1.97M | Add |
| Q2 2025 | 531.16K | $1.97M | Add |
| Q3 2025 | 273.50K | $2.38M | Reduce |
| Q4 2025 | 337.50K | $2.53M | Add |
| Q1 2026 | 124.32K | $1.16M | Reduce |
| Q2 2026 | 69.48K | $924.10K | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding FDMT
- BlackRock Inc 4.55M sh · $60.46M · Q2 2026
- Goldman Sachs Group 4.26M sh · $56.64M · Q2 2026
- Janus Henderson Group 5.25M sh · $48.87M · Q1 2026
- Vanguard Group 3.09M sh · $23.20M · Q4 2025
- Geode Capital Management 1.13M sh · $15.01M · Q2 2026
- Bank of America Corp 1.12M sh · $14.90M · Q2 2026
- Deutsche Bank AG 710.94K sh · $9.46M · Q2 2026
- Renaissance Technologies 614.57K sh · $8.17M · Q2 2026
- Northern Trust Corp 562.93K sh · $7.49M · Q2 2026
- Morgan Stanley 503.02K sh · $6.69M · Q2 2026
- JPMorgan Chase & Co 402.14K sh · $5.18M · Q2 2026
- Charles Schwab Investment Management 339.27K sh · $4.51M · Q2 2026